Serum free testosterone in men with coronary artery atherosclerosis

Medical Science Monitor

Volumn 9, Issue 5, 2003, Pages

  Siemińska, Lucyna ^a   Wojciechowska, Celina ^a   Świȩtochowska, Elzbieta ^a   Marek, Bogdan ^a   Kos Kudła, Beata ^a   Kajdaniuk, Dariusz ^a   Nowalany Kozielska, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Atherogenic lipids; Coronary artery disease; Sex hormones

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RADIOIMMUNOASSAY; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; HUMANS; MALE; MIDDLE AGED; TESTOSTERONE; TRIGLYCERIDES;

EID: 0038509867     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Heller RF, Jacobs HS, Vermeulen A, Deslypere JP: Androgens, oestrogens, and coronary heart disease. BMJ, 1981; 282: 438-9
2. Barrett-Connor E, Khaw KT: Endogenous sex hormones and cardiovascular disease in men. Circulation, 1988; 78: 539-45
3. Alexandersen P, Haarbo J, Christiansen C: The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis, 1996; 125: 1-13
4. Liu Y, Ding J, Bush TL et al: Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol, 2001; 154: 489-94
5. Phillips GB, Pinkernell BH, Jing TY: Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol, 1997; 17: 695-701
6. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ: The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis, 1998; 41: 1-15
7. Kamischke A, Heuermann T, Kruger K et al: An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J Clin Endocrinol Metab, 2002; 87: 530-9
8. Hak AE, Witteman JC, de Jong FH et al: Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab, 2002; 87: 3632-9
9. Gray A, Feldman HA, McKinlay JB, Longcope C: Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab, 1991; 73: 1016-25
10. Kabakci G, Yildirir A, Can I et al: Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography. Cardiology, 1999; 92: 221-5
11. Giagulli VA, Kaufman JM, Vermeulen A: Pathogenesis of decreased androgen levels in obese men. J Clin Endocrinol Metab, 1994; 79: 997-1000
12. Jockenhovel F, Blum WF, Vogel E et al: Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab, 1997; 82: 2510-3
13. English KM, Mandour O, Steeds RP et al: Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J, 2000; 21: 890-4
14. Semmens J, Rouse I, Beillin LJ, Masarec JR: Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women. Metabolism, 1983; 32: 428-32
15. Adams MR, Williams JK, Kaplan JR: Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol, 1995; 15: 562-70
16. Bruck B, Brehme U, Gugel N et al: Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol, 1997; 17: 2192-9
17. Alexandersen P, Haarbo J, Bytjalsen I et al: Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res, 1999; 84: 813-9
18. Simon D, Charles MA, Nahoul K et al: Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab, 1997; 82: 682-5
19. Phillips GB, Pinkernell BH, Jing TY: The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol, 1994; 14: 701-6
20. Yue P, Chatterjee K, Beale C et al: Testosterone relaxes rabbit coronary arteries and aorta. Circulation, 1996; 94: 2414-9
21. Costarella CE, Stallone JN, Rutecki GW, Whittier FC: Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther, 1996; 277: 34-9
22. Deenadayalu VP, White RE, Stallone JN et al: Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol, 2001; 281: 1720-7
23. Webb CM, McNeill JG, Hayward CS: Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation, 1999; 100: 1690-6
24. Ong PJ, Patrizi G, Chong WC et al: Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol, 2000; 85: 269-72
25. Webb CM, Adamson DL, de Zeigler D, Collins P: Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol, 1999; 83: 437-9
26. Hanke H, Lenz C, Hess B et al: Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation, 2001; 103: 1382-5
27. Nathan L, Shi W, Dinh H et al: Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase. Proc Natl Acad Sci, 2001; 98: 3589-93
28. Buchter D, Behre HM, Kliesch S et al: Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin. Exp Clin Endocrinol Diabetes, 1999; 107: 522-9
29. Haffner SM, Karhapaa P, Mykkanen L, Laakso M: Insulin resistance, body fat distribution and sex hormones in men. Diabetes, 1994; 43: 212-9
30. Grundy SM: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation, 2002; 105: 2696-8
31. Friedl KE, Hannan CJ, Jones RE, Plymate SR: High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism, 1990; 39: 69-77
32. Mȩdraś M, Jankowska E: Testosterone and atherosclerosis in males during andropause. Pol Merkurinsz Lek, 1999; 6: 205-7
33. Khaw KT, Barrett-Connor E: Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler Thromb, 1991; 11: 489-94